SCHEMBL1158459

SCHEMBL1158459

COc1cncc(-c2cc3cc[nH]c(=O)c3c(Nc3ccc(C4CCN(C(=O)[C@H](C)OC)CC4)c(C)c3)n2)n1

nearest known ligand 0.72

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ZAP70 P43403 18/20 0.72
SYK P43405 1/20 0.34
FER P16591 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1158064 1.00 ZAP70 (0.72) ZAP70SYKFER
SCHEMBL1158535 0.93 ZAP70 (0.71) ZAP70SYKFER
SCHEMBL1158544 0.92 ZAP70 (0.70) ZAP70
SCHEMBL6522861 0.91 ZAP70 (0.75) ZAP70FER
SCHEMBL6525190 0.91 ZAP70 (0.77) ZAP70SYKFER
SCHEMBL1158517 0.90 ZAP70 (0.75) ZAP70FER
SCHEMBL1158585 0.89 ZAP70 (0.69) ZAP70
SCHEMBL1158101 0.89 ZAP70 (0.74) ZAP70SYKFER
SCHEMBL1158522 0.89 ZAP70 (0.74) ZAP70SYKFER
SCHEMBL1158218 0.89 ZAP70 (0.74) ZAP70SYKFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110053897-A1 COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS IRM LLC (BM) 2011-03-03 US claimed
EP-2459556-A1 2, 7 -NAPHTHYRIDIN- 1 -ONE DERIVATIVES AS SYK KINASE INHIBITORS IRM LLC (BM) 2012-06-06 EP disclosed
US-20110053897-A1 COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS IRM LLC (BM) 2011-03-03 US disclosed
US-20110053897-A1 COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS IRM LLC (BM) 2011-03-03 US disclosed
WO-2011014515-A1 2, 7 -NAPHTHYRIDIN- 1 -ONE DERIVATIVES AS SYK KINASE INHIBITORS IRM LLC (BM) 2011-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053897-A1 COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS SYK, BTK, LYN ZAP70 5/4885SYK 1/4885FER 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.